Antifungal resistance in Aspergillus

被引：10

作者：

Chandrasekar, PH ^{[1
]}

机构：

[1] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI 48202 USA

来源：

MEDICAL MYCOLOGY | 2005年 / 43卷

关键词：

antifungal; Aspergillus; resistance;

D O I：

10.1080/13693780400029130

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

There are currently few data on drug resistance in Aspergillus, but the recent development of susceptibility tests have made it possible, to some extent, to study resistance in azoles and polyenes. This paper reviews the limited data available. The increased incidence of aspergillosis and the introduction of newer drugs make it important to continue to monitor closely trends in antifungal drug resistance.

引用

页码：S295 / S298

页数：4

共 23 条

[1] Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals [J].

Balajee, SA ;

Weaver, M ;

Imhof, A ;

Gribskov, J ;

Marr, KA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1197-1203

[2] Aspergillus: Rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999 [J].

Chandrasekar, PH ;

Cutright, JL ;

Manavathu, EK .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (04) :211-214

[3] In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole [J].

Dannaoui, E ;

Persat, F ;

Monier, MF ;

Borel, E ;

Piens, MA ;

Picot, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) :553-555

[4] Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients [J].

Dannaoui, E ;

Meletiadis, J ;

Tortorano, AM ;

Symoens, F ;

Nolard, N ;

Viviani, MA ;

Piens, MA ;

Lebeau, B ;

Verweij, PE ;

Grillot, R .

JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (02) :129-134

[5] Acquired itraconazole resistance in Aspergillus fumigatus [J].

Dannaoui, E ;

Borel, E ;

Monier, MF ;

Piens, MA ;

Picot, S ;

Persat, F .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (03) :333-340

[6] Itraconazole resistance in Aspergillus fumigatus [J].

Denning, DW ;

Venkateswarlu, K ;

Oakley, KL ;

Anderson, MJ ;

Manning, NJ ;

Stevens, DA ;

Warnock, DW ;

Kelly, SL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368

[7] Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin [J].

Gardiner, RE ;

Souteropoulos, P ;

Park, S ;

Perlin, DS .

MEDICAL MYCOLOGY, 2005, 43 :S299-S305

[8] Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole [J].

Imhof, A ;

Balajee, SA ;

Fredricks, DN ;

Englund, JA ;

Marr, KA .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) :743-746

[9] Itraconazole-amphotericin B antagonism in Aspergillus fumigatus:: an E-test-based strategy [J].

Kontoyiannis, DP ;

Lewis, RE ;

Sagar, N ;

May, G ;

Prince, RA ;

Rolston, KVI .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2915-2918

[10] In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis [J].

Lass-Flörl, C ;

Kofler, G ;

Kropshofer, G ;

Hermans, J ;

Kreczy, A ;

Dierich, MP ;

Niederwieser, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) :497-502

← 1 2 3 →